Filters
New drug applications approved by US FDA as of 01 - 15 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
The use of pranlukast in infants with respiratory syncytial virus (RSV) infections appears to help avoid the need for respiratory support, a recent Japan study has found.
In the treatment of children with poorly controlled asthma, the use of azithromycin helps improve asthma control and reduce exacerbations, according to a study.
Exposure to phthalates while still in the womb is associated with lower body mass index (BMI) z-scores in children, suggesting impaired growth, reports a recent meta-analysis. Prenatal exposure, on the other hand, does not seem to affect body fat percentage.
Risk prediction models including factors such as maternal smoking status, body mass index, and parity, can help predict small-for-gestational age (SGA) during pregnancy, a recent Japan study has found.
While children with brain tumours already suffer from impaired neurocognitive functions, radiotherapy appears to worsen these impairments, a new study has found.
Remote insulin pump training among young patients with type 1 diabetes (T1D) appears to be as safe as in-person training, suggest the results of a recent study.
In the paediatric population, children with obesity are especially vulnerable to the SARS-CoV-2 virus, a study has found.
Children with vision impairment often experience greater symptoms of depression and anxiety, according to a recent study. Surgical treatment helps improve these mental health symptoms.
Spells, tremors, and irritability are common and early findings in infants with vitamin B12 deficiency, a recent Norway study has found. Prenatal exposure to nitrous oxide, typically given during labour, may be a risk factor.
